SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
View HTML EX-101.INS - EX-101.INS |
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.
